Novel Radical Cyclization of N-Aziridinyl Imines

DOI: 10.1021/ja00026a041

Source and publish data:

Journal of the American Chemical Society p. 9882 - 9883 (1991)

Update date:2022-08-03

Topics:

Authors:

Kim, Sunggak

Kee, In Seo

Lee, Sangphil

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00026a041

Full text of DOI:10.1021/ja00026a041

Products guided by the article

Product name:2-{2-[(Z)-2-Phenyl-aziridin-1-ylimino]-propyl}-2-prop-2-ynyl-malonic acid diethyl ester

Cas No:137435-41-7

R&D Labs maybe for 137435-41-7

Borun Chemical Co.,Ltd.

Contact:+86-574- 87178138; 87297407

Address:No. 809, Liudingxingzuo, cangsong road, Ningbo, China
Yuan Shi(SuQian)Biotechnology Co.,Ltd

website:http://www.yuanshibio.com

Contact:+86-527-84226672

Address:jiangsu suqian
Lanzhou huibang biological chemical technology Co., LTD

Contact:0931-7843964

Address:NO.2011,Yannan Road,Chengguan,
Tianjin Bright Future Technology Co., Ltd

Contact:0086-22-58016666

Address:NO.136 DongTeng Lake Street Tianjin Economic and Technology Development Area,Tainjin,China
Lian Xing Chemical Co.,Ltd.

Contact:0792-8228321

Address:10TH Floor No.121 binjiang Road Xunyang District

Relevant to this article

N-propylbenzoguanamine sulfonic acid-functionalized magnetic nanoparticles: A novel and magnetically retrievable catalyst for the synthesis of 1,4-dihydropyridine derivatives

Doi:10.1002/jccs.201800120
(2018)
New saccharin derivatives as tyrosinase inhibitors

Doi:10.1016/j.bmc.2012.03.033
(2012)
Structure-activity relationships of 2′,5′-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists

Doi:10.1080/15257770.2012.671988
(2012)
Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model

Doi:10.1016/j.bmcl.2012.07.077
(2012)
Concise enantio- and diastereoselective total syntheses of fumagillol, RK-805, FR65814, ovalicin, and 5-demethylovalicin

Doi:10.1002/anie.200502826
(2006)
Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity

Doi:10.1021/acsmedchemlett.8b00631
(2019)

Article Doi